NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

Any time you are in the position to wait until approval (in this case, approval in other indications than GBM) you will have a much stronger foundation to negotiate. I just don't see NWBO in a position to co-fund a whole lot of future trials and I think it would delay approval in a lot if cancer indications that could be pushed to the forefront with an exclusive partner for each indication. An upfront payment would also give NWBO funds to do Direct trials. I am obviously not an expert in biotech, but looking at it from a pure business, shareholder value perspective. I am likely blinded by what I see as an amazing opportunity to create immense value for shareholders, based on other deals I have seen do exactly this. I am often wrong and I could be here too.